CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $480,338 | +230.1% | 17,634 | +169.7% | 0.00% | – |
| Q2 2023 | $145,522 | -34.5% | 6,539 | -36.2% | 0.00% | – |
| Q1 2023 | $222,022 | +57.5% | 10,251 | +47.9% | 0.00% | – |
| Q4 2022 | $141,000 | -0.7% | 6,933 | +24.9% | 0.00% | – |
| Q3 2022 | $142,000 | +21.4% | 5,551 | +16.4% | 0.00% | – |
| Q2 2022 | $117,000 | +254.5% | 4,770 | +24.0% | 0.00% | – |
| Q1 2022 | $33,000 | -52.9% | 3,847 | +10.4% | 0.00% | – |
| Q4 2021 | $70,000 | -43.5% | 3,485 | -44.2% | 0.00% | – |
| Q3 2021 | $124,000 | -11.4% | 6,242 | -1.0% | 0.00% | – |
| Q2 2021 | $140,000 | -51.0% | 6,303 | -46.1% | 0.00% | -100.0% |
| Q1 2021 | $286,000 | -6.5% | 11,698 | -0.2% | 0.00% | 0.0% |
| Q4 2020 | $306,000 | +1510.5% | 11,722 | +922.9% | 0.00% | – |
| Q3 2020 | $19,000 | +26.7% | 1,146 | +27.6% | 0.00% | – |
| Q2 2020 | $15,000 | +7.1% | 898 | -20.4% | 0.00% | – |
| Q1 2020 | $14,000 | – | 1,128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |